<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30323801</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Analysis of an Imported Subgenotype C2 Strain of Human Enterovirus 71 in Beijing, China, 2015.</ArticleTitle><Pagination><StartPage>2337</StartPage><MedlinePgn>2337</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2337</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2018.02337</ELocationID><Abstract><AbstractText><b>Background:</b> Subgenotype C4 of enterovirus 71 (EV71) is the predominant agent of Hand Foot and Mouth disease (HFMD) circulating in the mainland of China. For the first time, a subgenotype C2 of EV71 named SY30-2 was isolated from a HFMD case in Beijing, China. Since it is uncertain whether antibodies raised against subgenotype C4 of EV71 can protect C2 EV71, it is important to monitor and check the presence of cross-reactive antibodies against new EV71 subgenotypes. To find out the causes for the different NtAb, this study is to investigate the relationships between amino acid residue variations and cross-reactive antibodies against EV71 subgenotypes C2 and C4. <b>Methods:</b> Nucleotide and amino acid sequences from full-length genome sequence of SY30-2 were compared to EV71 reference strains. A microneutralization test was used to detect neutralizing antibody (NTAb) in the sera of subgenotype C4 of EV71 infected cases against SY30-2 and FY17 (a C4 isolate). The 3D structure of the viral capsid protein of SY30-2 was constructed. <b>Results:</b> Genome sequence and similarity plot analyses showed that SY30-2 shared the highest identity with subgenotype C2 of EV71 strains in every fragment of the genome. While the microneutralization test result showed that children infected with subgenotype C4 of EV71 had higher NTAb titers against FY17 than SY30-2 (<i>p</i> &lt; 0.001). The amino acid sequence comparison revealed that four amino acid residues VP1-22, VP1-31, VP1-249 and VP3-93 were highly conserved in subgenotype C4 of EV71 compared with the corresponding amino acid residues on subgenotype C2 of EV71 (<i>p</i> &lt; 0.05). Furthermore, the 3D-structure of viral capsid protein showed that VP1-22, VP1-31 and VP3-93 were located on the surface of virion. <b>Conclusion:</b> This is the first report of an EV71 subgenotype C2 isolated from HFMD in Beijing, China. Only a few antigenic variations on subgenotype C2 of EV71 could have led to a great decrease in NTAb titer. Thus, imported new genotypes and subgenotypes of EV71 should be closely monitored. The efficacy of available vaccines against new viruses should be evaluated as well.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center for Preventive Medicine Research, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Shunyi Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yindong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Beijing Shunyi Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Songjian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Beijing Shunyi Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Hongmei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Beijing Shunyi Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>XiaoXiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Beijing Xi Cheng Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Zhichao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center for Preventive Medicine Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenzeng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Beijing Shunyi Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Hongbo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Beijing Shunyi Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Yiwei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center for Preventive Medicine Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center for Preventive Medicine Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Da</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center for Preventive Medicine Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lijuan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center for Preventive Medicine Research, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Quanyi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center for Preventive Medicine Research, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antigenic variation</Keyword><Keyword MajorTopicYN="N">cross-protectivity</Keyword><Keyword MajorTopicYN="N">human enterovirus 71</Keyword><Keyword MajorTopicYN="N">neutralizing antibody</Keyword><Keyword MajorTopicYN="N">subgenotype C2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30323801</ArticleId><ArticleId IdType="pmc">PMC6172327</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2018.02337</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthur Huang K. Y., Chen M. F., Huang Y. C., Shih S. R., Chiu C. H., Lin J. J., et al. (2017). Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat. Commun. 8:762. 10.1038/s41467-017-00736-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00736-9</ArticleId><ArticleId IdType="pmc">PMC5624920</ArticleId><ArticleId IdType="pubmed">28970483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessaud M., Razafindratsimandresy R., Nougairede A., Joffret M. L., Deshpande J. M., Dubot-Peres A., et al. (2014). Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity. PLoS One 9:e90624. 10.1371/journal.pone.0090624</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0090624</ArticleId><ArticleId IdType="pmc">PMC3944068</ArticleId><ArticleId IdType="pubmed">24598878</ArticleId></ArticleIdList></Reference><Reference><Citation>Bey E., Golombick T. (1984). A comparison of three methods for titration of poliovirus vaccines. J. Virol. Methods 9 123&#x2013;130. 10.1016/0166-0934(84)90004-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-0934(84)90004-1</ArticleId><ArticleId IdType="pubmed">6096387</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B. A., Pallansch M. A. (1995). Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 39 195&#x2013;205. 10.1016/0168-1702(95)00087-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Zhang Q., Li J., Cao W., Zhang J. X., Zhang L., et al. (2010). Analysis of recombination and natural selection in human enterovirus 71. Virology 398 251&#x2013;261. 10.1016/j.virol.2009.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.12.007</ArticleId><ArticleId IdType="pubmed">20060995</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande J., Nadkarni S., Francis P. (2003). Enterovirus 71 isolated from a case of acute flaccid paralysis in India represents a new genotype. Curr. Sci. 84 1350&#x2013;1353.</Citation></Reference><Reference><Citation>Hoy N. Y., Leung A. K., Metelitsa A. I., Adams S. (2012). New concepts in median nail dystrophy, onychomycosis, and hand, foot, and mouth disease nail pathology. ISRN Dermat. 2012:680163. 10.5402/2012/680163</Citation><ArticleIdList><ArticleId IdType="doi">10.5402/2012/680163</ArticleId><ArticleId IdType="pmc">PMC3302018</ArticleId><ArticleId IdType="pubmed">22462009</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S. W., Kiang D., Smith D. J., Wang J. R. (2011). Evolution of re-emergent virus and its impact on enterovirus 71 epidemics. Exp. Biol. Med. 236 899&#x2013;908. 10.1258/ebm.2010.010233</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/ebm.2010.010233</ArticleId><ArticleId IdType="pubmed">21715436</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y. P., Lin T. L., Hsu L. C., Chen Y. J., Tseng Y. H., Hsu C. C., et al. (2010). Genetic diversity and C2-like subgenogroup strains of enterovirus 71, Taiwan, 2008. Virol. J. 7:277. 10.1186/1743-422X-7-277</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-277</ArticleId><ArticleId IdType="pmc">PMC2975644</ArticleId><ArticleId IdType="pubmed">20959020</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y. P., Lin T. L., Lin T. H., Wu H. S. (2013). Antigenic and genetic diversity of human enterovirus 71 from 2009 to 2012. Taiwan. PLoS One 8:e80942. 10.1371/journal.pone.0080942</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080942</ArticleId><ArticleId IdType="pmc">PMC3858369</ArticleId><ArticleId IdType="pubmed">24348916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyte J., Doolittle R. F. (1982). A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157 105&#x2013;132. 10.1016/0022-2836(82)90515-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-2836(82)90515-0</ArticleId><ArticleId IdType="pubmed">7108955</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. A., Yoon Y. S., Hyeon J. Y., Yoo J. S., Lee S. W., Lee J. W., et al. (2016). Sequence analysis of the first C2 subgenogroup strain of enterovirus 71 isolated in Korea. J. Clin. Virol. 85 13&#x2013;16. 10.1016/j.jcv.2016.10.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2016.10.012</ArticleId><ArticleId IdType="pubmed">27816018</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q., Cheng T., Zhu F., Li J., Wang Y., Li Y., et al. (2013). The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children. PLoS One 8:e79599. 10.1371/journal.pone.0079599</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079599</ArticleId><ArticleId IdType="pmc">PMC3834186</ArticleId><ArticleId IdType="pubmed">24260259</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand A., Schuffenecker I., Henquell C., Billaud G., Jugie G., Falcon D., et al. (2010). Phylogenetic evidence for a recent spread of two populations of human enterovirus 71 in European countries. J. Gen. Virol. 91 2263&#x2013;2277. 10.1099/vir.0.021741-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.021741-0</ArticleId><ArticleId IdType="pubmed">20505012</ArticleId></ArticleIdList></Reference><Reference><Citation>Pommie C., Levadoux S., Sabatier R., Lefranc G., Lefranc M. P. (2004). IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties. J. Mol. Recogn. 17 17&#x2013;32. 10.1002/jmr.647</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmr.647</ArticleId><ArticleId IdType="pubmed">14872534</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S., Singh S., Poh C. L., Chow V. T. (2002). The hand, foot and mouth disease virus capsid: sequence analysis and prediction of antigenic sites from homology modelling. Appl. Bioinformat. 1 43&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">15130856</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M. J., McMinn P., Ooi M. H. (2010). Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 10 778&#x2013;790. 10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z., Wang H., Xu A. (2012). Identification of a C2 subgenogroup strain of enterovirus 71 in a retrospective study in Shandong Province, China, from 1990 to 2010. J. Clin. Microbiol. 50 1823&#x2013;1824. 10.1128/JCM.06850-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.06850-11</ArticleId><ArticleId IdType="pmc">PMC3347126</ArticleId><ArticleId IdType="pubmed">22357503</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization [WHO] (2011). A Guide to Clinical Management and Public Health Response for Hand, Foot and Mouth disease(HFMD). Reginal Emerging Diseases Intervention. Geneva: WHO.</Citation></Reference><Reference><Citation>Xing W., Liao Q., Viboud C., Zhang J., Sun J., Wu J. T., et al. (2014). Hand, foot, and mouth disease in China, 2008&#x2013;12: an epidemiological study. Lancet Infect. Dis. 14 308&#x2013;318. 10.1016/S1473-3099(13)70342-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X. F., Gao S., Xia J. F., Ye R., Yu H., Long J. E. (2012). Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16. Scand. J. Infect. Dis. 44 297&#x2013;305. 10.3109/00365548.2011.634433</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365548.2011.634433</ArticleId><ArticleId IdType="pubmed">22176514</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Tan X. J., Wang H. Y., Yan D. M., Zhu S. L., Wang D. Y., et al. (2009). An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J. Clin. Virol. 44 262&#x2013;267. 10.1016/j.jcv.2009.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2009.02.002</ArticleId><ArticleId IdType="pubmed">19269888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z., Zhu S., Guo X., Wang J., Wang D., Yan D., et al. (2010). Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Virol. J. 7:300. 10.1186/1743-422X-7-300</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-300</ArticleId><ArticleId IdType="pmc">PMC2989968</ArticleId><ArticleId IdType="pubmed">21050463</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>